中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
29期
32-33
,共2页
石志良%周国强%彭建%郭健%韩复%余生元
石誌良%週國彊%彭建%郭健%韓複%餘生元
석지량%주국강%팽건%곽건%한복%여생원
直肠肿瘤%全系膜切除术%肿瘤特异系膜切除术
直腸腫瘤%全繫膜切除術%腫瘤特異繫膜切除術
직장종류%전계막절제술%종류특이계막절제술
Rectal neoplasms%Total mesorectal excision%Tumor-sepecific mesorectal excision
目的:通过直肠癌肿瘤特异系膜切除术(TSME)与直肠癌全系膜切除术(TME)临床效果的比较,探讨TSME的应用价值。方法DukesA、B、C期中低位直肠癌患者80例分为TSME组(42例)和TME组(38例),比较两组患者术后的复发率、存活率、吻合口瘘及直肠系膜内淋巴结清除情况,评价TSME的效果。结果 TSME组与TME组在手术后复发率、存活率、直肠系膜内淋巴结清除情况方面的比较,差异无统计学意义(P>0.05);TSME组吻合口瘘发生率明显低于TME组,差异具有统计学意义(P<0.05)。结论TSME能够保证直肠癌手术根治性,与TME手术比较, TSME手术能够减少并发症,值得临床推广应用。
目的:通過直腸癌腫瘤特異繫膜切除術(TSME)與直腸癌全繫膜切除術(TME)臨床效果的比較,探討TSME的應用價值。方法DukesA、B、C期中低位直腸癌患者80例分為TSME組(42例)和TME組(38例),比較兩組患者術後的複髮率、存活率、吻閤口瘺及直腸繫膜內淋巴結清除情況,評價TSME的效果。結果 TSME組與TME組在手術後複髮率、存活率、直腸繫膜內淋巴結清除情況方麵的比較,差異無統計學意義(P>0.05);TSME組吻閤口瘺髮生率明顯低于TME組,差異具有統計學意義(P<0.05)。結論TSME能夠保證直腸癌手術根治性,與TME手術比較, TSME手術能夠減少併髮癥,值得臨床推廣應用。
목적:통과직장암종류특이계막절제술(TSME)여직장암전계막절제술(TME)림상효과적비교,탐토TSME적응용개치。방법DukesA、B、C기중저위직장암환자80례분위TSME조(42례)화TME조(38례),비교량조환자술후적복발솔、존활솔、문합구루급직장계막내림파결청제정황,평개TSME적효과。결과 TSME조여TME조재수술후복발솔、존활솔、직장계막내림파결청제정황방면적비교,차이무통계학의의(P>0.05);TSME조문합구루발생솔명현저우TME조,차이구유통계학의의(P<0.05)。결론TSME능구보증직장암수술근치성,여TME수술비교, TSME수술능구감소병발증,치득림상추엄응용。
Objective To explore the application value of tumor-specific mesorectal excision (TSME) by comparing the clinical effects between TSME and total mesorectal excision (TME).Methods A total of 80 patients with Dukes A, B and C upper middle section of rectal cancer were divided into TSME group (n=42) and TME group (n=38). The recurrence rate, survival rate, anastomotic fistula and cleaning of lymphnode of mesentery were compared between the two groups, and effect of TSME was evaluated.Results There was no significant differences of recurrence rate, survival rate and cleaning of lymphnode of mesentery between the TSME group and the TME group (P>0.05). Incidence of anastomotic fistula of TSME group was significantly lower than that of the TME group, and the difference was statistically significant (P<0.05).Conclusion TSME can guarantee the radical excision of rectal cancer and reduce the incidence of complications, compared with TME, and it is worthy of clinical promotion.